UK Authorizes Once-Weekly Insulin for Type 2 Diabetes
Original Article: https://www.medscape.com/viewarticle/mhra-authorises-once-weekly-insulin-type-2-diabetes-2026a10012py
The AnnouncementThe United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Onswik (insulin efsitora alfa), a long-acting basal insulin administered once a week for adults with type 2 diabetes. Announced on October 13, 2026, … [Read More]

